Stocktoria

HEALTHY EXTRACTS INC. HYEX

OTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2015-10-13

HEALTHY EXTRACTS INC. financials (annual)

Revenue
$3.1M $4.5M 2024202420242024202520252025202520262026
Net income
$19.3M $19.1M $18.8M -$840671 $19.6M -$331739 $20.0M -$881119 $20.3M -$329486 2024202420242024202520252025202520262026
Free cash flow
2024202420242024202520252025202520262026

Bars are annual figures from 2024 to 2026; red bars are negative (a loss or cash outflow).

MetricFY2026FY2026FY2025FY2025FY2025FY2025FY2024FY2024FY2024FY2024
Revenue——$4.5M———$3.1M———
Gross profit——$2.4M———$1.9M———
Income tax——$0———$0———
Net income-$329,486$20.3M-$881,119$20.0M-$331,739$19.6M-$840,671$18.8M$19.1M$19.3M
Operating cash flow——$165,520———$281,968———
Inventory$644,114$520,752$843,357$966,522$1.1M$1.1M$1.4M$1.4M$1.3M$1.6M
Total assets$32.6M$27.3M$27.8M$26.2M$2.5M$2.4M$2.4M$2.5M$2.5M$2.6M
Total liabilities$10.2M$3.3M$3.8M$2.1M$2.0M—$2.0M———
Shareholders' equity$22.4M$24.0M$24.0M$24.1M$477,958$60,508$151,646$802,961$400,000$151,646

Growth · year-over-year · Revenue CAGR 44.9%

MetricFY2026FY2026FY2025FY2025FY2025FY2025FY2024FY2024FY2024FY2024
Net income growth-101.6%—-104.4%—-101.7%—-104.5%-1.9%-0.6%—

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.